뒤로
3D Medicines Inc.(01244.HK) 가격
01244.HK 주가 차트
3D MEDICINES (01244.HK)
3D Medicines Inc.
HK$5.51
-3.67%
$-0.2
장 종료: Jan 19, 16:00:00 HKT
아직 데이터 없음Earnings FAQ
01244.HK의 최근 주당순이익(EPS)은 예상과 비교하여 어떤가요?
3D Medicines Inc. 01244.HK의 지난 분기 매출 실적은 어땠나요?
3D Medicines Inc.의 매출 추정치는 얼마인가요?
3D Medicines Inc.의 수익 품질 점수는 얼마인가요?
3D Medicines Inc.는 언제 수익을 보고하나요?
3D Medicines Inc.의 예상 수익은 얼마인가요?
3D Medicines Inc.은 수익 기대치를 충족했나요?
주요 통계
이전 종가
$5.88
시가
$5.72
일일 범위
$5.44 - $5.73
52주 범위
$2.7 - $10.02
거래량
81.5K
평균 거래량
331.2K
EPS(TTM)
-0.77
배당수익률
--
시가총액
$1.3B
3D MEDICINES란 무엇인가요?
3D Medicines, Inc. is an investment holding company, which engages in biopharmaceutical research and development. The company is headquartered in Qingdao, Shandong and currently employs 183 full-time employees. The company went IPO on 2022-12-15. The firm focuses on the discovery, development and commercialization of innovative drugs in the field of cancer chronic disease treatment, and also lays out the field of cancer pain management. The firm has built a complete set of internal R&D systems, and has covered the entire process from drug discovery, preclinical development, clinical trials, and registration. The firm's first marketed drug, Envafolimab, is a subcutaneously injected PD-L1 inhibitor for the treatment of pan-tumor types. The firm also has a number of innovative drug research and development pipelines. The firm primarily operates in the domestic Chinese market.